Additional file 5 of Testing different models of pharmacy-based HIV pre- and post-exposure prophylaxis initiation and management in Kenya: protocol for a cluster-randomized controlled trial

Tabitha Kareithi; Stephanie D. Roche; Allison Meisner; Victor Ocholla Omollo; Patricia A. Ong’wen; Kendall Harkey; Catherine Kiptinness; Peris Otieno; Lawrence Juma; Rachel C. Malen; Micah O. Anyona; Kelly Curran; Banerjee Preetika; Eunice Gichuru; Magdaline Asewe; Kaiyue Yu; Jillian C. Pintye; Melissa Latigo Mugambi; Parth Shah; Monisha Sharma; Daniel Were; Kenneth Ngure; Elizabeth Anne Bukusi; Katrina F. Ortblad

doi:10.6084/m9.figshare.31237333

Additional file 5 of Testing different models of pharmacy-based HIV pre- and post-exposure prophylaxis initiation and management in Kenya: protocol for a cluster-randomized controlled trial

Figshare 2026 Open access

Read full text

Authors: Tabitha Kareithi, Stephanie D. Roche, Allison Meisner, Victor Ocholla Omollo, Patricia A. Ong’wen, Kendall Harkey, Catherine Kiptinness, Peris Otieno, Lawrence Juma, Rachel C. Malen, Micah O. Anyona, Kelly Curran

+12 more

Banerjee Preetika, Eunice Gichuru, Magdaline Asewe, Kaiyue Yu, Jillian C. Pintye, Melissa Latigo Mugambi, Parth Shah, Monisha Sharma, Daniel Were, Kenneth Ngure, Elizabeth Anne Bukusi, Katrina F. Ortblad

DOI: 10.6084/m9.figshare.31237333

Cited by: 0

Abstract

Additional file 8: Initiation assumptions. Number of PrEP and PEP initiations and continuations expected per pharmacy per month, by study arm. This table outlines the number of PrEP, PEP, and PrEP/PEP initiations and continuations we anticipated per pharmacy per month

Fields of Study & Subjects

HIV/AIDS Research and Interventions HIV Drug Use Sexual Risk HIV/AIDS drug development and treatment

Publication details

Journal / source: Figshare
Publication date: 1 January 2026